Care este prețul pentru G&E Herbal Biotechnology Co., Ltd. (4911)

Prețul pentru G&E Herbal Biotechnology Co., Ltd. (4911) este $0.91899191

Care este capitalizarea de piață pentru G&E Herbal Biotechnology Co., Ltd. (4911)

Capitalizarea de piață pentru G&E Herbal Biotechnology Co., Ltd. (4911) este $63.24M

Venituri G&E Herbal Biotechnology Co., Ltd. (4911)

G&E Herbal Biotechnology Co., Ltd. operates as a biopharmaceutical enterprise, concentrating on the innovation and commercialization of advanced botanical extraction technologies and the products derived from them. Its diverse portfolio features a range of botanical anti-aging cosmetic items, including facial foam cleansers, cleansing essences, toners, lightening lotions, essential oils, and moisturizing serums and creams, along with specialized products like the SR-100 botanical essence and bromelain illuminating cleansing mousse. The company also manufactures capsules designed as hepato-protective agents. In the realm of wellness, G&E offers a selection of botanical healthcare products such as ArthrEnergy, Jujubes Polysaccharide, Diabecut, HepatoClean, Astragali Radix, Goji, Prosta, and SR-100 capsules, as well as various products catering to adults. Looking to its future developments, the company is actively pursuing new treatments, including Solarise injection for gynecologic, head, and neck cancers; Apocin capsules intended for non-small cell lung cancer; and SR-T100 Gel, which targets common and genital warts. Beyond its own product lines, G&E Herbal Biotechnology is involved in creating manufacturing technologies for a wide array of dietary supplements and provides expert technical advisory services to other biotechnology organizations. The company was founded in 2002 and is headquartered in Tainan City, Taiwan.

An	Venituri	Schimbă
Nu sunt suficiente date pentru perioada selectată.

Venituri

Schimbă

Nu sunt suficiente date pentru perioada selectată.

Companie	Venituri	Diferență de venituri	Țara
Vertex Pharmaceuticals Incorporated VRTX.US	$12.62B	-	US
Argenx SE ARGX.US	$6.02B	-	NL
Moderna, Inc. MRNA.US	$2.23B	-	US
CSL Limited CSL.AX	$15.74B	-	AU
Lonza Group AG LONN.SW	-	-	CH

Companie

Venituri

Diferență de venituri

Țara